EnteroBiotix announces partnership with Imperial College London
Collaboration includes a phase 2 clinical trial using microbiome therapeutics funded by the MRC
Read More
Tag: EnteroBiotix
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
